Install
Airport and Flights
Routes, delays, expansions and everything at the airport.
- 4 Tracked terms
- Last 30 days Feed window
Where the coverage comes from
The 32 sources publishing most on Airport and Flights over the last 30 days, out of 40 articles in the feed. Click a source for its articles on this topic and its profile.
- 1
@Knowridgesci knowridge.com 5 articles 12.5% 2+ week ago 100%
- 2
The Clinical Trial Vanguard clinicaltrialvanguard.com 2 articles 5.0% 1+ week ago 100%
- 3
Life Science Nordic lifesciencenordic.com 2 articles 5.0% 1+ week ago 100%
- 4
@Dailymirror mirror.co.uk 2 articles 5.0% 1+ week ago 100%
- 5
Quiver Quantitative quiverquant.com 2 articles 5.0% 1+ week ago 0%
- 6
@Aol aol.co.uk 1 article 2.5% 1+ week ago 100%
- 7
@Asiae_Daily asiae.co.kr 1 article 2.5% 3+ week ago 100%
- 8
@Barchart barchart.com 1 article 2.5% 1+ week ago 100%
- 9
@Bbcnews bbc.co.uk 1 article 2.5% 1+ week ago 100%
- 10
Bbc bbc.com 1 article 2.5% 1+ week ago 100%
- 11
@Bpmcanada benefitsandpensionsmonitor.com 1 article 2.5% 1+ week ago 100%
- 12
@Yahoocanada ca.style.yahoo.com 1 article 2.5% 2+ week ago 100%
- 13
@Yahoofinance finance.yahoo.com 1 article 2.5% 2+ day ago 100%
- 14
India Blooms indiablooms.com 1 article 2.5% 2+ week ago 100%
- 15
@Inkl inkl.com 1 article 2.5% 3+ week ago 100%
- 16
Korea Biomedical Review koreabiomed.com 1 article 2.5% 2+ week ago 100%
- 17
@Labroots labroots.com 1 article 2.5% 2+ week ago 100%
- 18
Lambert-Eaton News lamberteatonnews.com 1 article 2.5% 3+ week ago 100%
- 19
Google News life.liga.net 1 article 2.5% 2+ week ago 0%
- 20
@Marketscreener1 marketscreener.com 1 article 2.5% 2+ week ago 100%
- 21
Medical Daily medicaldaily.com 1 article 2.5% 3+ week ago 100%
- 22
@Digitalmehmet medium.com 1 article 2.5% 3+ week ago 100%
- 23
Cnw Group newswire.ca 1 article 2.5% 1+ week ago 0%
- 24
Nbr_Magazine nutraceuticalbusinessreview.com 1 article 2.5% 3+ week ago 0%
- 25
@Nutraeurope nutraingredients.com 1 article 2.5% 1+ week ago 100%
- 26
Nutrition Insight nutritioninsight.com 1 article 2.5% 3+ week ago 0%
- 27
Openpr openpr.com 1 article 2.5% 3+ day ago 100%
- 28
Pharmatimes pharmatimes.com 1 article 2.5% 2+ week ago 100%
- 29
@Therecordernews recorder.com 1 article 2.5% 1+ week ago 100%
- 30
@Sciencealert sciencealert.com 1 article 2.5% 2+ week ago 100%
- 31
Scitechdaily scitechdaily.com 1 article 2.5% 2+ week ago 0%
- 32
@Stack3Dnews stack3d.com 1 article 2.5% 1+ week ago 100%
In the feed right now
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Airport and Flights
Perelel and Bluestone Lane Launch National Partnership Bringing Clinically Studied Triple-Support Protein to 65+ Cafés
2+ day, 13+ hour ago (355+ words) Yahoo Finance Oops, something went wrong U.S. markets close in 2h 6m Perelel and Bluestone Lane Launch National Partnership Bringing Clinically Studied Triple-Support Protein to 65+ Cafés Beginning September 10, Bluestone Lane introduces a year-long national partnership, with three seasonal drops featuring Perelel's clinically-proven Triple-Support…...
The Alzheimer's Agitation Non-Antipsychotic Drug Therapy Market is Projected to Experience Robust Growth with a 14.3% CAGR Forecast
3+ day, 13+ hour ago (65+ words) The Alzheimer's Agitation Non-Antipsychotic Drug Therapy openPR.com The Alzheimer's Agitation Non-Antipsychotic Drug Therapy Market is Projected to Experience Robust Growth with a 14.3% CAGR Forecast Press release from: The Business research company Permanent link to this press release: You can…...
Surrey and Borders trust joins Alzheimer's prevention drug trial
1+ week, 20+ hour ago (533+ words) The clinical trial is recruiting 1,600 healthy adults aged 55 to 80 internationally An NHS trust says it has become the first in Europe to join a trial examining if a new drug can delay or prevent the onset of Alzheimer's. Surrey and…...
Price cut becomes the price of coverage for Alzheimer's drug lecanemab
1+ week, 2+ day ago (417+ words) Canada's Drug Agency reversed its do-not-reimburse draft, and pCPA negotiations decide what plans pay next Canada's Drug Agency will back public reimbursement of the Alzheimer's treatment LEQEMBI (lecanemab) only if its price falls. Canada's Drug Agency (CDA-AMC) limited coverage to…...
Eisai and Biogen Announce China Approval of LEQEMBI SC-AI for Initiation Treatment of Early Alzheimer’s Disease | BIIB Stock News
1+ week, 2+ day ago (472+ words) LEQEMBI SC-AI approved in China for early Alzheimer's treatment, offering at-home administration options and reduced healthcare resource needs. LEQEMBI SC-AI is a subcutaneous autoinjector formulation of lecanemab, approved for treating mild cognitive impairment due to Alzheimer's disease. LEQEMBI SC-AI was…...
Ostrovit introduces its blend-style Protein Complex + DigeZyme
1+ week, 3+ day ago (249+ words) Stack3d BUY ONE GET ONE FREE AT NINJA Check out Stack3d's most popular stories before you go Ostrovit throws in DigeZyme to help differentiate its latest protein powder European supplement giant OstroVit already has plenty of traditional protein powders, and we…...
Canada backs reimbursement for BioArctic’s Leqembi
1+ week, 4+ day ago (133+ words) lifesciencenordic.com Bioarctic's research partner Eisai has received a final recommendation from Canada's drug agency supporting public reimbursement of Leqembi (lecanemab) for eligible patients with early Alzheimer's disease. Bioarctic said in a press release. Eli Lilly to acquire Merida Biosciences…...
Canada’s Drug Agency Issues Positive Reimbursement Recommendation for Lecanemab
1+ week, 4+ day ago (402+ words) The Clinical Trial Vanguard Canada’s Drug Agency Issues Positive Reimbursement Recommendation for Lecanemab Canada’s Drug Agency reversed course on lecanemab in roughly five months, flipping from a February 2026 recommendation against public reimbursement to a final positive recommendation issued September 1 — and…...
Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease
1+ week, 5+ day ago (125+ words) Barchart.com We've received your inquiry. A specialist will reach out within 1 business day. Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease All information and data in this article is solely…...
Eisai and Biogen Announce Canada’s Drug Agency Final Recommendation Supporting Public Reimbursement of LEQEMBI for Eligible Early Alzheimer’s Disease Patients | BIIB Stock News
1+ week, 5+ day ago (456+ words) Canada's Drug Agency recommends public reimbursement for LEQEMBI® in eligible Alzheimer’s patients, advancing access in Canada. LEQEMBI® is a monoclonal antibody designed to treat mild cognitive impairment or mild dementia due to Alzheimer’s disease. Canada’s Drug Agency (CDA-AMC) issued the…...